Evaluation of simple nucleic acid extraction methods for the detection of SARS-CoV-2 in nasopharyngeal and saliva specimens during global shortage of extraction kits
- PMID: 32629187
- PMCID: PMC7309780
- DOI: 10.1016/j.jcv.2020.104519
Evaluation of simple nucleic acid extraction methods for the detection of SARS-CoV-2 in nasopharyngeal and saliva specimens during global shortage of extraction kits
Abstract
Background: The severe shortage of nucleic acid extraction kits during the current COVID-19 pandemic represents a key limiting factor in testing capacity.
Objectives: This study compared the results of SARS-CoV-2 RT-PCR using different simple nucleic acid extraction methods on nasopharyngeal and saliva specimens.
Study design: Fifty nasopharyngeal swab and saliva specimens previously tested positive for SARS-CoV-2 were retrieved. Three different methods of nucleic acid extraction were compared. The first method involves incubating the specimen with proteinase K, and then heat treatment at 98 °C for 5 min (PKH); the second method involves heat treatment at 98 °C for 5 min without proteinase K pre-incubation (heat only); the third method involves no pre-processing steps (direct). The products from all 3 methods were tested by SARS-CoV-2 RT-PCR.
Results: PKH had significantly higher positive rate in SARS-CoV-2 RT-PCR (80 %) than those of heat only (58 %; P = 0.001) or direct (56 %; P = 0.002). The median Ct value was significantly earlier for PKH (median Ct: 37.0, IQR 31.7-40) than that of heat only (median Ct: 40, IQR 36.2-41; P < 0.0001) and direct (median Ct, 37.5; IQR 33.9-41.0; P = 0.0049). Subgroup analysis showed that PKH had higher detection rate, lower limit of detection and earlier Ct values than the other two groups for both NPS and saliva specimens.
Conclusions: PKH pre-processing resulted in the highest detection rate of SARS-CoV-2 by RT-PCR, and represents an alternative method for nucleic acid extraction when commercial extraction kits are not available.
Keywords: COVID-19; Detection; Nucleic acid extraction; Proteinase K; RT-PCR; SARS-CoV-2.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest None.
Figures
Similar articles
-
Comparative evaluation of nasopharyngeal swab and saliva specimens for the molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-19.J Infect Chemother. 2021 Jan;27(1):126-129. doi: 10.1016/j.jiac.2020.09.027. Epub 2020 Sep 30. J Infect Chemother. 2021. PMID: 33060046 Free PMC article.
-
Value of swab types and collection time on SARS-COV-2 detection using RT-PCR assay.J Virol Methods. 2020 Dec;286:113974. doi: 10.1016/j.jviromet.2020.113974. Epub 2020 Sep 16. J Virol Methods. 2020. PMID: 32949663 Free PMC article.
-
Detection of SARS-CoV-2 RNA by direct RT-qPCR on nasopharyngeal specimens without extraction of viral RNA.PLoS One. 2020 Jul 24;15(7):e0236564. doi: 10.1371/journal.pone.0236564. eCollection 2020. PLoS One. 2020. PMID: 32706827 Free PMC article.
-
Alternative clinical specimens for the detection of SARS-CoV-2: A rapid review.Rev Med Virol. 2021 Jul;31(4):e2185. doi: 10.1002/rmv.2185. Epub 2020 Oct 22. Rev Med Virol. 2021. PMID: 33091200 Review.
-
New COVID-19 saliva-based test: How good is it compared with the current nasopharyngeal or throat swab test?J Chin Med Assoc. 2020 Oct;83(10):891-894. doi: 10.1097/JCMA.0000000000000396. J Chin Med Assoc. 2020. PMID: 32773584 Free PMC article. Review.
Cited by
-
Utility of Extraction-Free SARS-CoV-2 Detection by RT-qPCR for COVID-19 Testing in a Resource-Limited Setting.Diseases. 2024 Aug 26;12(9):198. doi: 10.3390/diseases12090198. Diseases. 2024. PMID: 39329867 Free PMC article.
-
Assessment of DNA/RNA Defend Pro: An Inactivating Sample Collection Buffer for Enhanced Stability, Extraction-Free PCR, and Rapid Antigen Testing of Nasopharyngeal Swab Samples.Int J Mol Sci. 2024 Aug 22;25(16):9097. doi: 10.3390/ijms25169097. Int J Mol Sci. 2024. PMID: 39201783 Free PMC article.
-
An Open One-Step RT-qPCR for SARS-CoV-2 detection.PLoS One. 2024 Jan 25;19(1):e0297081. doi: 10.1371/journal.pone.0297081. eCollection 2024. PLoS One. 2024. PMID: 38271448 Free PMC article.
-
Optimization of nucleic acid extraction methods for rapid detection in pandemic situations or diseases with high prevalence.J Pharm Anal. 2023 Dec;13(12):1577-1579. doi: 10.1016/j.jpha.2023.08.005. Epub 2023 Aug 12. J Pharm Anal. 2023. PMID: 38223451 Free PMC article.
-
Dry Swab-Based Nucleic Acid Extraction vs. Spin Column-Based Nucleic Acid Extraction for COVID-19 RT-PCR Testing: A Comparative Study.Can J Infect Dis Med Microbiol. 2023 Aug 23;2023:6624932. doi: 10.1155/2023/6624932. eCollection 2023. Can J Infect Dis Med Microbiol. 2023. PMID: 37663452 Free PMC article.
References
-
- Peto J. Covid-19 mass testing facilities could end the epidemic rapidly. BMJ. 2020;368:m1163. - PubMed
-
- Hung I.F., Lung K.C., Tso E.Y., Liu R., Chung T.W., Chu M.Y. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020 doi: 10.1016/S0140-6736(20)31042-31044. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous